Adverse event reporting in haematological malignancies with the authors of our Adverse Events Series
Blood cancer treatments are advancing fast — but so are their side effects. Hear from the authors of The Lancet Haematology's Adverse Event reporting series on better trial design, patient-centric care, and what part 2 (2026) reveals about long-term toxicity, survivorship, regulation, and digital health tools.
Click here to visit the series hub on thelancet.com:
https://www.thelancet.com/series-do/adverse-events-in-haematology-oncology
The Lancet Haematology in conversation with... is part of the Lancet Group podcast offering.
Editorial team: editor-in-chief Lan-Lan Smith, deputy editor Emma Cookson, and senior editor Daniela Marin
Podcast editing: Matteo Simonetti
Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.
Find the best science for better lives at www.thelancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Mais episódios de "The Lancet Haematology in conversation with"
Não percas um episódio de “The Lancet Haematology in conversation with” e subscrevê-lo na aplicação GetPodcast.
